Article
My research shows that up to 50% of rheumatologists measure something in the course of their daily assessments, and RAPID3 is most popular, being employed by 31% of rheumatologists.
All News
Article
There were several hot topics at ACR21. Here I concentrate on top abstracts in vasculitis.
Article
The GLORIA study (ABST# 1678) was a pragmatic, blinded placebo-controlled randomized trial from Dr. Martin Boers and colleagues where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.
Dr. John Cush
Tweet
Herpes Zoster and Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD) reviews abstract #0981 presented at the #ACR21 annual meeting.
https://t.co/M95XQOBWVf https://t.co/X9vaAEAias
Dr. John Cush
Tweet
JAKi Safety: Dr. Aurelie Najm ( @AurelieRheumo) interviews Dr. Choy about JAKi safety data, including abstracts #0958, #1940 and #1941 presented at the #ACR21 annual meeting.
https://t.co/yZnM9ttDYv https://t.co/eKrocRZdbl
Dr. John Cush
Tweet
Type 1 and Type II Lupus — Patient Perspectives: Dr. Mehta ( @bella_mehta) interviews Dr. Clowse about abstract #1277 presented at the #ACR21 annual meeting
https://t.co/00ojx9rXut https://t.co/bO9chTneoV
Dr. John Cush
Tweet
Redefining Aging
The American College of Rheumatology put together the Community Aging Hub and multiple sessions to help rheumatologists identify gaps in care for older patients with rheumatic diseases
https://t.co/9ciS6oDncK https://t.co/oPZrFU0dmQ
Dr. John Cush
Tweet
GLORIA Study - Is Prednisone Harmful in Elder RA?
The GLORIA study (ABST#1678) was a pragmatic, blinded placebo-controlled randomized trial where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.
https://t.co/eKXjiDpHlc https://t.co/JtCgc1uZnE
Dr. John Cush
Tweet
Osteoporosis in PsA: Dr. Rachel Tate ( @uptoTate) discusses Abstract #1325, presented at the #ACR21 annual meeting.
https://t.co/xnRkPnHeTr https://t.co/nE3ehhCB4j
Dr. John Cush
Tweet
Real Time Monitoring of Disease Activity? There's An App for That: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts #0811 and #0373 presented at the #ACR21 annual meeting.
https://t.co/2qeZjhtMU4 https://t.co/MPCA3oox1U
Dr. John Cush
Tweet
Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan ( @synovialjoints) interviews Dr. FitzGerald about abstract #0490 and other PsA highlights being presented at the #ACR21 annual meeting.
https://t.co/WVgcE8TVpZ https://t.co/1uOafjFWPg
Dr. John Cush
Tweet
RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi ( @MeralElRamahiMD) reports on abstract #0633 presented at the #ACR21 annual meeting.
https://t.co/DO7YXhD3YA https://t.co/vcegdPx8OL
Dr. John Cush
Tweet
First JAKi Failure: What next? Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract #1442 presented at the #ACR21 annual meeting.
https://t.co/NCO8VeNsjb https://t.co/bSN34AFTtt
Dr. John Cush
Tweet
Career Advice for Young Rheumatologists: Drs. Janet Pope ( @Janetbirdope) asks Dr. Bykerk for her career advice for young rheumatologists, during the #ACR21 annual meeting.
https://t.co/jv0eYeFR7M https://t.co/WfYFXPwMtI
Dr. John Cush
Tweet
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 at the #ACR21 meeting.
https://t.co/jWDeA2aZqJ
@drdavidliew @swethaann23 @MeralElRamahiMD @DrMiniDey @doctorRBC https://t.co/KcE67BXcvp
Dr. John Cush
Tweet
TNF Inhibitors Rise to the Top: Drs. Janet Pope ( @Janetbirdope) and David Liew ( @drdavidliew) discuss TNF inhibitor data presented at the #ACR21 annual meeting, including abstracts #0087, #0990 and #0958.
https://t.co/G02P1vG7VQ https://t.co/BLZX5BPzEF
Dr. John Cush
Tweet
Data from ASN Kidney Wk 2021; US Renal Data System of 275,651 dialysis pts - 15% had gout Vs 85% without gout; Gout pts were older, more male, obese, had more hospitalizations (66 vs 57%), mortality, more CVD, PVD and MI https://t.co/m1d0SJEJjw
Dr. John Cush
Tweet
Best of SpA Abstracts Day 2: Dr. Robert Chao ( @doctorRBC) shares the best of SpA Abstracts from Day 2 of #ACR21.
https://t.co/8oZipxMLCm https://t.co/jAifqBRgVc
Dr. John Cush
Tweet
Early Rheumatoid Arthritis: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Vivian Bykerk about her work in early RA and CATCH (Canadian Early Arthritis Cohort) Study Group, during the #ACR21 annual meeting.
https://t.co/DGazNdTFTU https://t.co/K318MIkxvy
Dr. John Cush
Tweet
Vitamin D and Hydroxychloroquine Studies: Dr. Michelle Petri discussed studies regarding Vitamin D supplementation and as well as data on hydroxychloroquine that was presented Saturday at the #ACR21 annual meeting.
https://t.co/CU8wFVYhNg
